Gardner Lewis Asset Management’s Eli Lilly LLY Stock Holding History

Gardner Lewis Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.73M	Sell	5,148 -81	-2%	-$82.1K	1.03%	34
2025 Q4	$5.62M	Buy	5,229 +292	+6%	+$279K	1.42%	23
2025 Q3	$3.77M	Sell	4,937 -54	-1%	-$40.2K	0.89%	31
2025 Q2	$3.89M	Buy	4,991 +145	+3%	+$113K	0.97%	37
2025 Q1	$4M	Buy	4,846 +2,398	+98%	+$2M	0.96%	41
2024 Q4	$1.89M	Sell	2,448 -2	-0.1%	-$1.66K	0.46%	47
2024 Q3	$2.17M	Hold	2,450	–	–	0.61%	44
2024 Q2	$2.22M	Hold	2,450	–	–	0.61%	45
2024 Q1	$1.91M	Buy	+2,450	New	+$1.74M	0.52%	46
2022 Q1	–	Sell	-5,966	Closed	-$1.65M	–	80
2021 Q4	$1.65M	Buy	+5,966	New	+$1.51M	0.31%	60

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Gardner Lewis Asset Management's LLY Position: Q1 2026 in Review

Gardner Lewis Asset Management reduced its Eli Lilly (LLY) stake by 1.5% in Q1 2026, selling an estimated $82.1K and leaving 5,148 shares worth $4.73M. The position accounts for 1.03% of the portfolio, ranked #34.

Gardner Lewis Asset Management first reported a position in LLY in Q4 2021 and has held it in 10 quarters since. The position peaked at $5.62M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Gardner Lewis Asset Management held 5,148 shares of Eli Lilly worth $4.73M as of Q1 2026.
Gardner Lewis Asset Management sold 81 Eli Lilly shares in Q1 2026, an estimated $82.1K.
Eli Lilly made up 1.03% of Gardner Lewis Asset Management's portfolio in Q1 2026, its #34 holding.
Gardner Lewis Asset Management first reported a position in Eli Lilly in Q4 2021 and has held it in 10 quarters since.
Gardner Lewis Asset Management's Eli Lilly position peaked at $5.62M in Q4 2025.
4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Gardner Lewis Asset Management's 13F filing for Q1 2026, filed 8 May 2026.